|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
Q4 FY2021
As of Jun 30, 2021
|
Q3 FY2021
As of Mar 31, 2021
|
Q2 FY2021
As of Dec 31, 2020
|
Q1 FY2021
As of Sep 30, 2020
|
Q4 FY2020
As of Jun 30, 2020
|
Q3 FY2020
As of Mar 31, 2020
|
Q2 FY2020
As of Dec 31, 2019
|
Q1 FY2020
As of Sep 30, 2019
|
Q4 FY2019
As of Jun 30, 2019
|
Q3 FY2019
As of Mar 31, 2019
|
Q2 FY2019
As of Dec 31, 2018
|
Q1 FY2019
As of Sep 30, 2018
|
Q4 FY2018
As of Jun 30, 2018
|
Q3 FY2018
As of Mar 31, 2018
|
Q2 FY2018
As of Dec 31, 2017
|
Q1 FY2018
As of Sep 30, 2017
|
Q4 FY2017
As of Jun 30, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash held for customers | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable net of allowances for doubtful accounts of $747 at March 31, 2022 and $1,304 at June 30, 2021 | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Customer account liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Borrowings under credit facility | ||||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Preferred Stock, $.001 par value: Authorized shares—4,000; issued and outstanding shares-none | ||||||||||||||||||||
| Common Stock, $.001 par value: Authorized shares-100,000; issued shares- 49,809 at December 31, 2021 and 49,294 at June 30, 2021; outstanding shares- 42,667 at December 31, 2021 and 43,237 at June 30, 2021 | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock: 7,060 shares at March 31, 2022 and 6,057 shares at June 30, 2021, at cost | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
